Log on / register
Feedback | Support | My details
Sensitization and translocation of TRPV1 by insulin and IGF-I.
Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS
Mol Pain 2005, 1:17
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.
Raisinghani M, Pabbidi RM, Premkumar LS
J Physiol 2005 Sep 15, 567:771-86
 [PubMed Central] [PubMed] [Related articles]
2.
Protein kinase C in pain: involvement of multiple isoforms.
Velázquez KT, Mohammad H, Sweitzer SM
Pharmacol Res 2007 Jun, 55:578-89
 [PubMed Central] [PubMed] [Related articles]
3.
Inflammatory pain: the cellular basis of heat hyperalgesia.
Huang J, Zhang X, McNaughton PA
Curr Neuropharmacol 2006 Jul, 4:197-206
 [PubMed Central] [PubMed] [Related articles]
4.
The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor.
Holzer P
Br J Pharmacol 2008 Dec, 155:1145-62
 [PubMed Central] [PubMed] [Related articles]
5.
TRPV1: A Target for Next Generation Analgesics.
Premkumar LS, Sikand P
Curr Neuropharmacol 2008 Jun, 6:151-63
 [PubMed Central] [PubMed] [Related articles]
6.
Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors.
Marks DR, Tucker K, Cavallin MA, Mast TG, Fadool DA
J Neurosci 2009 May 20, 29:6734-51
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.